| Company/Division name | Bausch + Lomb |
| Parent company | Valeant Pharmaceuticals |
| Type of work | Manufacturing |
| If manufacturing, is the company an OEM? | Yes |
| Reshoring category: | Transplant |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2013 |
| Year reshoring implemented or to be implemented: | 2013 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 106 |
| Country(ies) from which reshored: | Canada,Ireland |
| City reshored to: | Rochester |
| State(s) reshored to: | NY |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | Contact lenses |
| What domestic positive factors made reshoring more attractive? | Government Incentives |
